Clinical Trials Logo

Cardiovascular Disease clinical trials

View clinical trials related to Cardiovascular Disease.

Filter by:

NCT ID: NCT00121550 Completed - Clinical trials for Cardiovascular Disease

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

Start date: October 1999
Phase: Phase 3
Study type: Interventional

A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with clarithromycin 500 mg daily in patients already suffering from stable coronary heart disease. The participants will be followed for at least two years after the treatment. Abbott Laboratories supplied Clarithromycin and placebo tablets.

NCT ID: NCT00120107 Completed - Clinical trials for Cardiovascular Disease

Tea's Effect on Atherosclerosis Pilot Study (TEA Study)

Start date: July 2003
Phase: N/A
Study type: Interventional

The researchers propose a pilot study of the effect of long-term tea intake on atherosclerosis. Thirty patients at high risk for cardiovascular disease will be recruited and randomized to a six-month period of consumption of 3 cups per day of either tea, supplied as black tea solids readily dissolved in hot or cold liquid, or water. At baseline and after 6 months, atherosclerosis in the aorta will be assessed using magnetic resonance imaging. The primary outcomes of this pilot study will be compliance with tea intake and 2 MRI examinations. As secondary outcomes, standard and novel cardiovascular risk markers, including inflammatory, prothrombotic, fibrinolytic, vascular and metabolic factors will be measured. If successful, this pilot study will form the basis for a larger, long-term randomized trial to determine the effect of tea consumption on progression of atherosclerosis.

NCT ID: NCT00115232 Completed - Inflammation Clinical Trials

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Start date: July 2004
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (cases), and healthy children without such a family history (controls). The design is a cross-sectional study, gathering a fasting blood sample and clinical and behavioral data on children and a parent.

NCT ID: NCT00100451 Completed - Clinical trials for Cardiovascular Disease

Aging, Exercise, and Hormonal Influences of Fat Metabolism

Start date: June 1994
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether exercise alters the way in which the body stores and breaks down fat. A second objective is to evaluate how these effects are influenced by your age and gender. These studies are important because aging, male gender, and menopause are associated with an increased storage of abdominal fat which is frequently accompanied by diabetes, a high blood cholesterol level, high blood pressure and greater risks of heart attack, stroke, and death. Increasing evidence suggests that these abnormalities and many other effects of aging may be partly due to lack of exercise.

NCT ID: NCT00099450 Completed - Clinical trials for Cardiovascular Disease

Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers

Start date: December 2004
Phase: Phase 1
Study type: Interventional

The objectives of this study are to look at the safety and tolerability of the experimental drug, how people process the drug, how the drug affects people, and to identify a dose or doses to study in subsequent future studies.

NCT ID: NCT00099151 Completed - Diabetes Mellitus Clinical Trials

CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy

Start date: March 2002
Phase: N/A
Study type: Interventional

This study is one of three CALERIE trials that test the hypothesis that a reduced calorie, nutritionally sound diet improves biomarkers of aging and prevents some age-related chronic diseases such as cancer, diabetes, and cardiovascular disease. The three sites that are participating in the CALERIE trial represent a diversity of subject populations and interventional strategies.

NCT ID: NCT00095654 Completed - Clinical trials for Cardiovascular Disease

The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Start date: July 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if ramipril and/or rosiglitazone prevent the onset of type 2 diabetes.

NCT ID: NCT00093236 Completed - Clinical trials for Cardiovascular Disease

Impact of Gum Infection on Heart Disease

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of gum infection on parameters of cardio-vascular disease.

NCT ID: NCT00079963 Completed - Clinical trials for Cardiovascular Disease

Gender, Obesity, C-Reactive Protein, and Oxidative Stress

Start date: April 2004
Phase: N/A
Study type: Interventional

This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.

NCT ID: NCT00079586 Completed - Clinical trials for Cardiovascular Disease

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

Start date: April 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that in patients undergoing coronary artery bypass grafting (CABG) or CABG-Valve, or Isolated Cardiac Valve surgery on CPB (cardiac surgery), Angiomax is a safe and effective alternative anticoagulant to heparin with protamine reversal.